Articles related to Hematology/Oncology

Fixed-duration venetoclax-based therapy demonstrates sustained efficacy in CLL, with 65.2% of first-line patients remaining treatment-free five years after completion.

Cancer correlation analysis reveals that persistent thrombocytosis at six months carries an 18.1% cancer risk in males and 10.1% in females, with lung and colorectal malignancies predominating.

Five-year survival rates for chronic lymphocytic leukemia show promising outcomes even in elderly patients, with 77% survival in those 75 and older.

Recent studies suggest that ultra-processed foods may raise cancer risk by up to 10% for pancreatic, colorectal, and breast cancers, highlighting the importance of dietary considerations in cancer prevention.

Luspatercept demonstrates superior efficacy in achieving transfusion independence for patients with low-risk MDS compared to traditional erythropoiesis-stimulating agents.

Striking the balance between confidence and humility is crucial for new oncology attendings, especially when managing rare cases.